Hyperphosphatemia management among hemodialysis patients in the COVID-19 pandemic situation Hyperphosphatemia, hemodialysis patients, a transtheoretical model and motivational interviewing
Conditions
Interventions
The investigator helps manage hyperphosphatemia for hemodialysis patients and has developed a set of activities to control serum phosphorus among experimental group participants by using A transtheore
Experimental Behavioral,Active Comparator Behavioral
A transtheoretical model-based intervention and motivational interviewing on hyperphosphatemia management via telehealth among hemodialysis patients in COVID-19 pandemic situation : TMT program,Stand
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. End-stage renal disease (ESRD) patients who have undergone hemodialysis for a minimum of 3 months. 2. Serum phosphate level greater than or equal to 5.5 mg/dL or an average serum phosphate level greater than or equal to 5.5 mg/dL over 3 months. 3. Adequate hemodialysis, determined by a Kt/V value greater than or equal to 1.8 for patients undergoing hemodialysis twice a week and a Kt/V value greater than or equal to 1.2 for patients undergoing hemodialysis three times a week. 4. No history of parathyroidectomy. 5. Ability to use Line application or other communication tools independently or with assistance to facilitate communication throughout the study. 6. No malnutrition, as assessed by the Malnutrition Inflammation Score (MIS). 7. Proficiency in the Thai language, including reading, writing, and comprehension. 8. Willingness and ability to actively participate in the study throughout its duration.
Exclusion criteria
Exclusion criteria: 1. Change of address/relocation or move of domicile 2. Require hospitalization as a patient due to prolonged illness and unable to participate in program activities.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum phosphorus level 6 months Blood tests for checking the level of serum phosphorus and comparing the mean difference of serum phosphorus level (mg/dl) between intervention and control groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| The level of knowledge about the management of hyperphosphatemia, adherence to phosphate binders, and the level of dietary consumption behavior of foods containing phosphorus 6 months Questionnaires the score of knowledge about hyperphosphatemia management, medication adherence, and the dietary consumption behavior of foods containing phosphorus. | — |
Countries
Thailand
Contacts
Public ContactArrom Thongsunti
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed